Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.1000
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
ASX:LDX Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 15.43 | 1.96 | 6.48 | 3.02 | 7.98 |
Cash & Short-Term Investments | 15.43 | 1.96 | 6.48 | 3.02 | 7.98 |
Cash Growth | 688.80% | -69.81% | 114.89% | -62.21% | -82.23% |
Accounts Receivable | 2.22 | 3.37 | 1.57 | 0.89 | 1.71 |
Other Receivables | - | - | 0.11 | 0.6 | 0.18 |
Receivables | 2.22 | 3.37 | 1.68 | 1.49 | 1.89 |
Inventory | 1.64 | 0.52 | 0.78 | 1.06 | 2.53 |
Prepaid Expenses | 0.52 | 0.62 | 0.61 | 0.4 | 1.05 |
Total Current Assets | 19.81 | 6.46 | 9.56 | 5.96 | 13.44 |
Property, Plant & Equipment | 7.45 | 6.17 | 7.6 | 8.56 | 10.97 |
Other Intangible Assets | 13.49 | 2.81 | 3.32 | 3.7 | 4.38 |
Long-Term Deferred Charges | - | 5.38 | 6.37 | 7.19 | 8.15 |
Total Assets | 40.75 | 20.81 | 26.84 | 25.42 | 36.94 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 3.14 | 1.37 | 0.55 | 1.14 | 1.45 |
Accrued Expenses | 1.97 | 1.68 | 1.72 | 1.54 | 1.09 |
Short-Term Debt | - | - | - | 1.35 | - |
Current Portion of Leases | 1.06 | 1.05 | 0.95 | 0.69 | 0.97 |
Current Unearned Revenue | 6.84 | 3.07 | 7.57 | 1.71 | 6.66 |
Other Current Liabilities | - | 1.55 | 1.84 | 1.75 | 2.66 |
Total Current Liabilities | 13.01 | 8.72 | 12.62 | 8.17 | 12.83 |
Long-Term Leases | 4.88 | 5.94 | 7.11 | 7.75 | 6.23 |
Total Liabilities | 17.89 | 14.66 | 19.73 | 15.92 | 19.06 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 123.13 | 103.96 | 98.23 | 92.47 | 92.14 |
Retained Earnings | -102.76 | -97.84 | -90.86 | -82.29 | -74.53 |
Comprehensive Income & Other | 2.49 | 0.04 | -0.26 | -0.68 | 0.28 |
Total Common Equity | 22.86 | 6.16 | 7.11 | 9.5 | 17.89 |
Shareholders' Equity | 22.86 | 6.16 | 7.11 | 9.5 | 17.89 |
Total Liabilities & Equity | 40.75 | 20.81 | 26.84 | 25.42 | 36.94 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 5.94 | 6.99 | 8.06 | 9.79 | 7.19 |
Net Cash (Debt) | 9.49 | -5.03 | -1.58 | -6.77 | 0.78 |
Net Cash Growth | - | - | - | - | -97.88% |
Net Cash Per Share | 0.01 | -0.01 | -0.00 | -0.03 | 0.01 |
Filing Date Shares Outstanding | 851.17 | 748.52 | 481.31 | 443.44 | 209.91 |
Total Common Shares Outstanding | 851.17 | 748.52 | 481.31 | 309.42 | 209.91 |
Working Capital | 6.79 | -2.25 | -3.07 | -2.21 | 0.61 |
Book Value Per Share | 0.03 | 0.01 | 0.01 | 0.03 | 0.09 |
Tangible Book Value | 9.37 | 3.35 | 3.79 | 5.8 | 13.5 |
Tangible Book Value Per Share | 0.01 | 0.00 | 0.01 | 0.02 | 0.06 |
Machinery | - | 1.14 | 1.46 | 1.75 | 3.55 |
Construction In Progress | - | 0.02 | 0.02 | 0.16 | 1.38 |
Leasehold Improvements | - | 0.07 | 0.07 | 0.06 | 0.79 |